Request for Covid-19 Impact Assessment of this Report
The United States Thrombin (Human) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Thrombin (Human) market, reaching US$ million by the year 2028. As for the Europe Thrombin (Human) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Thrombin (Human) players cover Baxter, AMRESCO Inc, BD Biosciences, and Life Technologies Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Thrombin (Human) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
500IU/Vial
1000IU/Vial
2500IU/Vial
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Biotechnology
Medicine
Microbiology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Thrombin (Human) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Thrombin (Human) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Thrombin (Human) by Country/Region, 2017, 2022 & 2028
2.2 Thrombin (Human) Segment by Type
2.2.1 500IU/Vial
2.2.2 1000IU/Vial
2.2.3 2500IU/Vial
2.3 Thrombin (Human) Sales by Type
2.3.1 Global Thrombin (Human) Sales Market Share by Type (2017-2022)
2.3.2 Global Thrombin (Human) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Thrombin (Human) Sale Price by Type (2017-2022)
2.4 Thrombin (Human) Segment by Application
2.4.1 Biotechnology
2.4.2 Medicine
2.4.3 Microbiology
2.4.4 Others
2.5 Thrombin (Human) Sales by Application
2.5.1 Global Thrombin (Human) Sale Market Share by Application (2017-2022)
2.5.2 Global Thrombin (Human) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Thrombin (Human) Sale Price by Application (2017-2022)
3 Global Thrombin (Human) by Company
3.1 Global Thrombin (Human) Breakdown Data by Company
3.1.1 Global Thrombin (Human) Annual Sales by Company (2020-2022)
3.1.2 Global Thrombin (Human) Sales Market Share by Company (2020-2022)
3.2 Global Thrombin (Human) Annual Revenue by Company (2020-2022)
3.2.1 Global Thrombin (Human) Revenue by Company (2020-2022)
3.2.2 Global Thrombin (Human) Revenue Market Share by Company (2020-2022)
3.3 Global Thrombin (Human) Sale Price by Company
3.4 Key Manufacturers Thrombin (Human) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thrombin (Human) Product Location Distribution
3.4.2 Players Thrombin (Human) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Thrombin (Human) by Geographic Region
4.1 World Historic Thrombin (Human) Market Size by Geographic Region (2017-2022)
4.1.1 Global Thrombin (Human) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Thrombin (Human) Annual Revenue by Geographic Region
4.2 World Historic Thrombin (Human) Market Size by Country/Region (2017-2022)
4.2.1 Global Thrombin (Human) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Thrombin (Human) Annual Revenue by Country/Region
4.3 Americas Thrombin (Human) Sales Growth
4.4 APAC Thrombin (Human) Sales Growth
4.5 Europe Thrombin (Human) Sales Growth
4.6 Middle East & Africa Thrombin (Human) Sales Growth
5 Americas
5.1 Americas Thrombin (Human) Sales by Country
5.1.1 Americas Thrombin (Human) Sales by Country (2017-2022)
5.1.2 Americas Thrombin (Human) Revenue by Country (2017-2022)
5.2 Americas Thrombin (Human) Sales by Type
5.3 Americas Thrombin (Human) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thrombin (Human) Sales by Region
6.1.1 APAC Thrombin (Human) Sales by Region (2017-2022)
6.1.2 APAC Thrombin (Human) Revenue by Region (2017-2022)
6.2 APAC Thrombin (Human) Sales by Type
6.3 APAC Thrombin (Human) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Thrombin (Human) by Country
7.1.1 Europe Thrombin (Human) Sales by Country (2017-2022)
7.1.2 Europe Thrombin (Human) Revenue by Country (2017-2022)
7.2 Europe Thrombin (Human) Sales by Type
7.3 Europe Thrombin (Human) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Thrombin (Human) by Country
8.1.1 Middle East & Africa Thrombin (Human) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Thrombin (Human) Revenue by Country (2017-2022)
8.2 Middle East & Africa Thrombin (Human) Sales by Type
8.3 Middle East & Africa Thrombin (Human) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thrombin (Human)
10.3 Manufacturing Process Analysis of Thrombin (Human)
10.4 Industry Chain Structure of Thrombin (Human)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thrombin (Human) Distributors
11.3 Thrombin (Human) Customer
12 World Forecast Review for Thrombin (Human) by Geographic Region
12.1 Global Thrombin (Human) Market Size Forecast by Region
12.1.1 Global Thrombin (Human) Forecast by Region (2023-2028)
12.1.2 Global Thrombin (Human) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Thrombin (Human) Forecast by Type
12.7 Global Thrombin (Human) Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Thrombin (Human) Product Offered
13.1.3 Baxter Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 AMRESCO Inc
13.2.1 AMRESCO Inc Company Information
13.2.2 AMRESCO Inc Thrombin (Human) Product Offered
13.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AMRESCO Inc Main Business Overview
13.2.5 AMRESCO Inc Latest Developments
13.3 BD Biosciences
13.3.1 BD Biosciences Company Information
13.3.2 BD Biosciences Thrombin (Human) Product Offered
13.3.3 BD Biosciences Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BD Biosciences Main Business Overview
13.3.5 BD Biosciences Latest Developments
13.4 Life Technologies Corporation
13.4.1 Life Technologies Corporation Company Information
13.4.2 Life Technologies Corporation Thrombin (Human) Product Offered
13.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Life Technologies Corporation Main Business Overview
13.4.5 Life Technologies Corporation Latest Developments
13.5 PromoCell GmbH
13.5.1 PromoCell GmbH Company Information
13.5.2 PromoCell GmbH Thrombin (Human) Product Offered
13.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 PromoCell GmbH Main Business Overview
13.5.5 PromoCell GmbH Latest Developments
13.6 Sigma-Aldrich Corporation
13.6.1 Sigma-Aldrich Corporation Company Information
13.6.2 Sigma-Aldrich Corporation Thrombin (Human) Product Offered
13.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sigma-Aldrich Corporation Main Business Overview
13.6.5 Sigma-Aldrich Corporation Latest Developments
13.7 Vitrolife AB
13.7.1 Vitrolife AB Company Information
13.7.2 Vitrolife AB Thrombin (Human) Product Offered
13.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Vitrolife AB Main Business Overview
13.7.5 Vitrolife AB Latest Developments
13.8 CSL
13.8.1 CSL Company Information
13.8.2 CSL Thrombin (Human) Product Offered
13.8.3 CSL Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CSL Main Business Overview
13.8.5 CSL Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Thrombin (Human) Product Offered
13.9.3 Bayer Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Grifols
13.10.1 Grifols Company Information
13.10.2 Grifols Thrombin (Human) Product Offered
13.10.3 Grifols Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Grifols Main Business Overview
13.10.5 Grifols Latest Developments
13.11 Octapharma
13.11.1 Octapharma Company Information
13.11.2 Octapharma Thrombin (Human) Product Offered
13.11.3 Octapharma Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Octapharma Main Business Overview
13.11.5 Octapharma Latest Developments
13.12 Shanghai RAAS
13.12.1 Shanghai RAAS Company Information
13.12.2 Shanghai RAAS Thrombin (Human) Product Offered
13.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Shanghai RAAS Main Business Overview
13.12.5 Shanghai RAAS Latest Developments
13.13 Hualan Biological
13.13.1 Hualan Biological Company Information
13.13.2 Hualan Biological Thrombin (Human) Product Offered
13.13.3 Hualan Biological Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hualan Biological Main Business Overview
13.13.5 Hualan Biological Latest Developments
14 Research Findings and Conclusion
Table 1. Thrombin (Human) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Thrombin (Human) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 500IU/Vial
Table 4. Major Players of 1000IU/Vial
Table 5. Major Players of 2500IU/Vial
Table 6. Global Thrombin (Human) Sales by Type (2017-2022) & (K Units)
Table 7. Global Thrombin (Human) Sales Market Share by Type (2017-2022)
Table 8. Global Thrombin (Human) Revenue by Type (2017-2022) & ($ million)
Table 9. Global Thrombin (Human) Revenue Market Share by Type (2017-2022)
Table 10. Global Thrombin (Human) Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Thrombin (Human) Sales by Application (2017-2022) & (K Units)
Table 12. Global Thrombin (Human) Sales Market Share by Application (2017-2022)
Table 13. Global Thrombin (Human) Revenue by Application (2017-2022)
Table 14. Global Thrombin (Human) Revenue Market Share by Application (2017-2022)
Table 15. Global Thrombin (Human) Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Thrombin (Human) Sales by Company (2020-2022) & (K Units)
Table 17. Global Thrombin (Human) Sales Market Share by Company (2020-2022)
Table 18. Global Thrombin (Human) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Thrombin (Human) Revenue Market Share by Company (2020-2022)
Table 20. Global Thrombin (Human) Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Thrombin (Human) Producing Area Distribution and Sales Area
Table 22. Players Thrombin (Human) Products Offered
Table 23. Thrombin (Human) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Thrombin (Human) Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Thrombin (Human) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Thrombin (Human) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Thrombin (Human) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Thrombin (Human) Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Thrombin (Human) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Thrombin (Human) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Thrombin (Human) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Thrombin (Human) Sales by Country (2017-2022) & (K Units)
Table 35. Americas Thrombin (Human) Sales Market Share by Country (2017-2022)
Table 36. Americas Thrombin (Human) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Thrombin (Human) Revenue Market Share by Country (2017-2022)
Table 38. Americas Thrombin (Human) Sales by Type (2017-2022) & (K Units)
Table 39. Americas Thrombin (Human) Sales Market Share by Type (2017-2022)
Table 40. Americas Thrombin (Human) Sales by Application (2017-2022) & (K Units)
Table 41. Americas Thrombin (Human) Sales Market Share by Application (2017-2022)
Table 42. APAC Thrombin (Human) Sales by Region (2017-2022) & (K Units)
Table 43. APAC Thrombin (Human) Sales Market Share by Region (2017-2022)
Table 44. APAC Thrombin (Human) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Thrombin (Human) Revenue Market Share by Region (2017-2022)
Table 46. APAC Thrombin (Human) Sales by Type (2017-2022) & (K Units)
Table 47. APAC Thrombin (Human) Sales Market Share by Type (2017-2022)
Table 48. APAC Thrombin (Human) Sales by Application (2017-2022) & (K Units)
Table 49. APAC Thrombin (Human) Sales Market Share by Application (2017-2022)
Table 50. Europe Thrombin (Human) Sales by Country (2017-2022) & (K Units)
Table 51. Europe Thrombin (Human) Sales Market Share by Country (2017-2022)
Table 52. Europe Thrombin (Human) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Thrombin (Human) Revenue Market Share by Country (2017-2022)
Table 54. Europe Thrombin (Human) Sales by Type (2017-2022) & (K Units)
Table 55. Europe Thrombin (Human) Sales Market Share by Type (2017-2022)
Table 56. Europe Thrombin (Human) Sales by Application (2017-2022) & (K Units)
Table 57. Europe Thrombin (Human) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Thrombin (Human) Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Thrombin (Human) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Thrombin (Human) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Thrombin (Human) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Thrombin (Human) Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Thrombin (Human) Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Thrombin (Human) Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Thrombin (Human) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Thrombin (Human)
Table 67. Key Market Challenges & Risks of Thrombin (Human)
Table 68. Key Industry Trends of Thrombin (Human)
Table 69. Thrombin (Human) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Thrombin (Human) Distributors List
Table 72. Thrombin (Human) Customer List
Table 73. Global Thrombin (Human) Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Thrombin (Human) Sales Market Forecast by Region
Table 75. Global Thrombin (Human) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Thrombin (Human) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Thrombin (Human) Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Thrombin (Human) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Thrombin (Human) Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Thrombin (Human) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Thrombin (Human) Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Thrombin (Human) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Thrombin (Human) Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Thrombin (Human) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Thrombin (Human) Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Thrombin (Human) Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Thrombin (Human) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Thrombin (Human) Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Thrombin (Human) Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Thrombin (Human) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Thrombin (Human) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Thrombin (Human) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Baxter Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Thrombin (Human) Product Offered
Table 95. Baxter Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Baxter Main Business
Table 97. Baxter Latest Developments
Table 98. AMRESCO Inc Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 99. AMRESCO Inc Thrombin (Human) Product Offered
Table 100. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. AMRESCO Inc Main Business
Table 102. AMRESCO Inc Latest Developments
Table 103. BD Biosciences Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Biosciences Thrombin (Human) Product Offered
Table 105. BD Biosciences Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. BD Biosciences Main Business
Table 107. BD Biosciences Latest Developments
Table 108. Life Technologies Corporation Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 109. Life Technologies Corporation Thrombin (Human) Product Offered
Table 110. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Life Technologies Corporation Main Business
Table 112. Life Technologies Corporation Latest Developments
Table 113. PromoCell GmbH Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 114. PromoCell GmbH Thrombin (Human) Product Offered
Table 115. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. PromoCell GmbH Main Business
Table 117. PromoCell GmbH Latest Developments
Table 118. Sigma-Aldrich Corporation Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 119. Sigma-Aldrich Corporation Thrombin (Human) Product Offered
Table 120. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Sigma-Aldrich Corporation Main Business
Table 122. Sigma-Aldrich Corporation Latest Developments
Table 123. Vitrolife AB Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 124. Vitrolife AB Thrombin (Human) Product Offered
Table 125. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Vitrolife AB Main Business
Table 127. Vitrolife AB Latest Developments
Table 128. CSL Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 129. CSL Thrombin (Human) Product Offered
Table 130. CSL Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. CSL Main Business
Table 132. CSL Latest Developments
Table 133. Bayer Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 134. Bayer Thrombin (Human) Product Offered
Table 135. Bayer Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Bayer Main Business
Table 137. Bayer Latest Developments
Table 138. Grifols Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 139. Grifols Thrombin (Human) Product Offered
Table 140. Grifols Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Grifols Main Business
Table 142. Grifols Latest Developments
Table 143. Octapharma Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 144. Octapharma Thrombin (Human) Product Offered
Table 145. Octapharma Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 146. Octapharma Main Business
Table 147. Octapharma Latest Developments
Table 148. Shanghai RAAS Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanghai RAAS Thrombin (Human) Product Offered
Table 150. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 151. Shanghai RAAS Main Business
Table 152. Shanghai RAAS Latest Developments
Table 153. Hualan Biological Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors
Table 154. Hualan Biological Thrombin (Human) Product Offered
Table 155. Hualan Biological Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 156. Hualan Biological Main Business
Table 157. Hualan Biological Latest Developments
List of Figures
Figure 1. Picture of Thrombin (Human)
Figure 2. Thrombin (Human) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Thrombin (Human) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Thrombin (Human) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Thrombin (Human) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 500IU/Vial
Figure 10. Product Picture of 1000IU/Vial
Figure 11. Product Picture of 2500IU/Vial
Figure 12. Global Thrombin (Human) Sales Market Share by Type in 2021
Figure 13. Global Thrombin (Human) Revenue Market Share by Type (2017-2022)
Figure 14. Thrombin (Human) Consumed in Biotechnology
Figure 15. Global Thrombin (Human) Market: Biotechnology (2017-2022) & (K Units)
Figure 16. Thrombin (Human) Consumed in Medicine
Figure 17. Global Thrombin (Human) Market: Medicine (2017-2022) & (K Units)
Figure 18. Thrombin (Human) Consumed in Microbiology
Figure 19. Global Thrombin (Human) Market: Microbiology (2017-2022) & (K Units)
Figure 20. Thrombin (Human) Consumed in Others
Figure 21. Global Thrombin (Human) Market: Others (2017-2022) & (K Units)
Figure 22. Global Thrombin (Human) Sales Market Share by Application (2017-2022)
Figure 23. Global Thrombin (Human) Revenue Market Share by Application in 2021
Figure 24. Thrombin (Human) Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Thrombin (Human) Revenue Market Share by Company in 2021
Figure 26. Global Thrombin (Human) Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Thrombin (Human) Revenue Market Share by Geographic Region in 2021
Figure 28. Global Thrombin (Human) Sales Market Share by Region (2017-2022)
Figure 29. Global Thrombin (Human) Revenue Market Share by Country/Region in 2021
Figure 30. Americas Thrombin (Human) Sales 2017-2022 (K Units)
Figure 31. Americas Thrombin (Human) Revenue 2017-2022 ($ Millions)
Figure 32. APAC Thrombin (Human) Sales 2017-2022 (K Units)
Figure 33. APAC Thrombin (Human) Revenue 2017-2022 ($ Millions)
Figure 34. Europe Thrombin (Human) Sales 2017-2022 (K Units)
Figure 35. Europe Thrombin (Human) Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Thrombin (Human) Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Thrombin (Human) Revenue 2017-2022 ($ Millions)
Figure 38. Americas Thrombin (Human) Sales Market Share by Country in 2021
Figure 39. Americas Thrombin (Human) Revenue Market Share by Country in 2021
Figure 40. United States Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Thrombin (Human) Sales Market Share by Region in 2021
Figure 45. APAC Thrombin (Human) Revenue Market Share by Regions in 2021
Figure 46. China Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Thrombin (Human) Sales Market Share by Country in 2021
Figure 53. Europe Thrombin (Human) Revenue Market Share by Country in 2021
Figure 54. Germany Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Thrombin (Human) Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Thrombin (Human) Revenue Market Share by Country in 2021
Figure 61. Egypt Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Thrombin (Human) in 2021
Figure 67. Manufacturing Process Analysis of Thrombin (Human)
Figure 68. Industry Chain Structure of Thrombin (Human)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...